We are live on ! Find out more
AICPI

ABG Innovation Capital Partners III Portfolio holdings

AUM $64.5K
1-Year Est. Return 1.01%
This Fund
S&P 500
This Quarter Est. Return
-30.2%
1 Year Est. Return
+1.01%
3 Year Est. Return
+5.56%
5 Year Est. Return
-85.52%
10 Year Est. Return
AUM
$732K
AUM Growth
-$355K
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSTL icon
1
Castle Biosciences
CSTL
$949M
$461K 63%
33,626
WHWK
2
Whitehawk Therapeutics
WHWK
$208M
$182K 24.91%
26,666
SYBX
3
DELISTED
Synlogic
SYBX
$88.5K 12.09%
13,727

Similar funds

ABG Innovation Capital Partners III's Q2 2023 Portfolio in Review

As of Q2 2023, ABG Innovation Capital Partners III held 3 positions worth $732K, down 33% from $1.09M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2023: portfolio turnover was 0%. ABG Innovation Capital Partners III opened no new positions and made no exits, leaving the 3-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • ABG Innovation Capital Partners III's ten largest holdings make up 100% of its $732K portfolio in Q2 2023.
  • ABG Innovation Capital Partners III opened 0 new positions and closed 0 in Q2 2023.
  • ABG Innovation Capital Partners III's portfolio value fell 33% quarter-over-quarter to $732K.

Based on ABG Innovation Capital Partners III's 13F filing for Q2 2023, filed 14 Aug 2023.